Ayurveda Global Export Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Ayurveda Global Export Pharmaceutical Export Portfolio Dataset — 2 Products, $16.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ayurveda Global Export — Pharmaceutical Exporter Profile (2026) | 2 Products, $16.1K Trade | TransData Nexus

Ayurveda Global Export

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $16.1K Total Trade · DGFT Verified

Ayurveda Global Export is an Indian pharmaceutical exporter with a total trade value of $16.1K across 2 products in 1 therapeutic categories. Based on 149 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Kwatha ($13.9K), Ghrita ($2.2K), .

Ayurveda Global Export — Export Portfolio & Destination Treemap

Ayurveda Global Export pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Ayurveda Global Export? — Company Overview & Market Position

Ayurveda Global Export is an Indian pharmaceutical exporter specializing in finished Ayurvedic formulations, including tablets, capsules, syrups, and injections. Established in Chennai, India, the company has developed a niche in exporting Ayurvedic products to various international markets. While specific details regarding the company's founding year, ownership structure, and employee count are not publicly disclosed, its consistent export activity underscores its operational stability. The company's website, www.ayurvedakerala.com, serves as a portal for product information and export inquiries.

What Does Ayurveda Global Export Export? — Product Portfolio Analysis

Top Products by Export Value

1Kwatha$13.9K 2Ghrita$2.2K

Ayurveda Global Export Therapeutic Categories — 1 Specializations

Ayurveda Global Export operates across 1 therapeutic categories, with representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Product Portfolio — Top 2 by Export Value

Ayurveda Global Export exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Kwatha	Ayurvedic & Herbal Products	$13.9K	109	2.6%	11
2	Ghrita	Ayurvedic & Herbal Products	$2.2K	40	0.5%	11

Ayurveda Global Export exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $16.1K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Ayurveda Global Export — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific information about Ayurveda Global Export's manufacturing facilities, including their locations, capacities, and specializations, is not publicly available. The absence of detailed data suggests that the company may operate in partnership with contract manufacturers or utilize third-party facilities to produce its Ayurvedic formulations. This approach is common among exporters aiming to maintain flexibility and scalability in production.

3Key Leadership

Detailed information regarding the key leadership of Ayurveda Global Export, such as the CEO, CFO, and other executives, is not publicly disclosed. The lack of accessible leadership data may indicate a preference for maintaining a low public profile or could be due to the company's relatively small scale in the international market.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Ayurveda Global Export Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Ayurveda Global Export's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly documented. The company's export data indicates shipments primarily to Singapore and Malaysia, suggesting a focus on markets with less stringent regulatory requirements for Ayurvedic products. The U.S. Food and Drug Administration (FDA) has previously identified safety concerns with certain Ayurvedic products, including the presence of heavy metals like lead, mercury, and arsenic, which can pose health risks to consumers. This regulatory scrutiny may influence Ayurveda Global Export's market access and necessitate compliance with international standards to enter these regulated markets.

2Emerging Markets

Ayurveda Global Export's export data indicates shipments primarily to Singapore and Malaysia, suggesting a focus on markets with less stringent regulatory requirements for Ayurvedic products. The company's export activities in these regions may be facilitated by the World Health Organization's (WHO) prequalification program, which aims to ensure the quality, safety, and efficacy of medical products. However, specific details regarding WHO prequalification or other certifications are not publicly available, making it challenging to assess the company's compliance with international standards.

Geographic Strategy

Ayurveda Global Export — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Ayurveda Global Export's interactions with the U.S. Food and Drug Administration (FDA), including facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history, is not publicly available. The absence of such data suggests that the company may not currently export to the United States or has not sought FDA approvals for its products. Given the FDA's stringent regulations and the identified safety concerns with certain Ayurvedic products, obtaining FDA approval would be a significant undertaking for the company.

2WHO & EU GMP

Specific information regarding Ayurveda Global Export's compliance with World Health Organization (WHO) prequalification, European Union Good Manufacturing Practice (EU GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly available. The lack of such certifications may limit the company's ability to access certain international markets that require adherence to these standards.

3CDSCO & Indian Regulatory

Ayurveda Global Export — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Ayurveda Global Export operates in a competitive landscape with numerous companies exporting Ayurvedic products globally. While specific competitors are not identified, the market includes both large-scale manufacturers and smaller exporters. Companies like Arogya Formulations Pvt. Ltd. and Songara All Ayurvedic have established a significant presence in the export of Ayurvedic products, offering a wide range of formulations and catering to various international markets. Ayurveda Global Export's focus on specific markets and product lines may provide a niche advantage but also exposes it to competitive pressures from both established and emerging players.

2Key Differentiators

Ayurveda Global Export's key differentiators include its specialization in finished Ayurvedic formulations and its focus on markets with less stringent regulatory requirements. However, the lack of publicly available information regarding certifications, manufacturing facilities, and leadership may limit its appeal to potential partners and customers seeking transparency and compliance with international standards.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Ayurveda Global Export as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Specific information regarding Ayurveda Global Export's supplier assessment, including track record, export volume, consistency, and reliability indicators, is not publicly available. The absence of such data makes it challenging to evaluate the company's supply chain robustness and its ability to meet international demand consistently.

2Certifications to Verify

Importers should verify the following certifications when considering Ayurveda Global Export as a supplier:

FDA Registration: Confirm that the company's manufacturing facilities are registered with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure compliance with World Health Organization's Good Manufacturing Practice standards.

EU GMP Certification: Verify adherence to European Union Good Manufacturing Practice standards.

Frequently Asked Questions — Ayurveda Global Export

How many pharmaceutical products does Ayurveda Global Export export from India?

Ayurveda Global Export exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Kwatha ($13.9K), Ghrita ($2.2K). Total export value is $16.1K.

What is Ayurveda Global Export's total pharmaceutical export value?

Ayurveda Global Export's total pharmaceutical export value is $16.1K, based on 149 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Ayurveda Global Export cover?

Ayurveda Global Export exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Ayurveda Global Export Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.